4.7 Review

Recent progress in understanding the pathology of malignant melanoma

Journal

JOURNAL OF PATHOLOGY
Volume 219, Issue 4, Pages 400-409

Publisher

WILEY
DOI: 10.1002/path.2617

Keywords

melanoma; ephrinA2; FGFR2; PTEN; BRAF; TGF-beta; p16(INK4A); p14(ARF); IGFBP7; p53; stem cell marker; ABCB5; Nodal; Snail; CYLD; MITF; mesenchymal-elongated-type and rounded-amoeboid mode of movement; LKB1; AMPK

Funding

  1. DFG
  2. German Cancer Foundation (German Melanoma Network)
  3. Wilhelm Sander Foundation

Ask authors/readers for more resources

Recently, several important findings on melanoma development and progression have accelerated progress towards a molecular understanding of melanoma biology. Furthermore, the development of experimental tools, such as a wide range of cell lines and animal models of metastasis, has turned melanoma into a model for general tumour research. However, it has also become evident that melanoma is distinct from other tumours with regard to its cellular origin and pathophysiological mechanisms. This review focuses on important new findings that have contributed to a greater understanding of the molecular processes leading to melanoma. Translating these innovative new results into potent therapeutic approaches will require even more effort. Copyright (C) 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available